跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 400 条关于
“Alyglo”
全部
400
临床试验
343
药物
30
机构
2
资讯
25
去年
GC Biopharma Expands U.S. Plasma Collection Network with FDA Approval of Calexico Facility
去年
GC Biopharma Advances Two-Dose Varicella Vaccine BARYCELA to Phase 3 Trial in Thailand
去年
Repare Therapeutics' Gynecological Cancer Trial Shows Mixed Results, Beigene Inks $1.5B Deal for MAT2A Inhibitor
去年
GC Biopharma Expands Asian Presence with Thai Red Cross Partnership for Plasma-Derived Therapeutics
11个月前
GC Biopharma Partners with Curevo Vaccine to Manufacture Next-Generation Shingles Vaccine with Improved Tolerability
25天前
GC Biopharma's Hunterase wins approval in India and Taiwan, expanding reach in Asia's rare disease market
去年
GC Biopharma's Hunterase Shows Significant Efficacy in Phase 3 Trial for Hunter Syndrome
6年前
MRD Monitoring Predicts Relapse Risk Post-Allo-HSCT in AML Patients
去年
ALLO-316 Receives FDA RMAT Designation for CD70+ Advanced Renal Cell Carcinoma
去年
ALLO-316 Granted RMAT Designation by FDA for Advanced Renal Cell Carcinoma
第 1 页,共 3 页
上一页
下一页